Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease

D. G. Clark | Charles D. Smith | Jason J. Corneveaux | C. Carlson | K. Lunetta | D. Geschwind | J. Gilbert | H. Hakonarson | J. Buxbaum | J. Haines | M. Pericak-Vance | G. Schellenberg | J. Morris | C. DeCarli | R. Green | B. Miller | J. Schneider | L. Schneider | D. Bennett | A. Myers | C. Cotman | T. Montine | M. Mesulam | R. Petersen | J. Trojanowski | J. Karlawish | D. Blacker | J. Growdon | B. Hyman | D. Perl | B. Reisberg | J. Hardy | A. Saykin | P. S. St George-Hyslop | S. Gilman | D. Mash | A. Levey | J. Kaye | R. Mayeux | M. Sano | B. Boeve | J. Cummings | O. Lopez | S. DeKosky | D. Galasko | G. Jicha | E. Masliah | M. Frosch | D. Dickson | J. Parisi | J. Quinn | A. Goate | N. Cairns | B. Ghetti | J. Ringman | E. Reiman | E. Martin | L. Honig | S. Arnold | L. Farrer | M. Barmada | P. Gallins | H. Chui | W. Seeley | K. Welsh-Bohmer | E. Bigio | S. Weintraub | R. Tanzi | M. Gearing | P. Nowotny | M. Carrasquillo | S. Younkin | Carlos Cruchaga | J. Glass | H. Vinters | Denis A. Evans | P. D. De Jager | W. Kukull | T. Foroud | P. Crane | D. Beekly | L. Harrell | J. Troncoso | J. Kauwe | A. Boxer | A. Karydas | D. Marson | M. Huentelman | J. Lah | M. Ganguli | Jacqueline Buros | A. McDavid | T. Bird | A. Naj | G. Jun | G. Beecham | B. Vardarajan | C. Baldwin | E. Larson | E. Rogaeva | D. Tsuang | K. Faber | L. Cantwell | Li-San Wang | T. Beach | G. Jarvik | J. Vonsattel | R. Rosenberg | N. Graff-Radford | A. McKee | R. Stern | B. Giordani | M. Farlow | N. Kowall | C. Hulette | R. Woltjer | E. Roberson | S. Ferris | E. Peskind | N. Ertekin-Taner | J. Bowen | W. McCormick | S. McCurry | F. Demirci | J. Burke | J. Corneveaux | R. Diaz-Arrastia | W. Mack | M. Kamboh | W. Ellis | E. Head | M. Raskind | A. Lieberman | R. Kim | N. Johnson | R. Hamilton | R. Barber | R. Carney | S. Carroll | M. Dick | K. Fallon | Lee-way Jin | E. Koo | P. Kramer | F. Martiniuk | C. Miller | Joshua W. Miller | W. Poon | J. Sonnen | S. Spina | J. Williamson | R. Rajbhandary | M. Shelanski | M. Slifer | V. Deerlin | B. Dombroski | Lee‐way Jin | B. Miller | Lee-Way Jin | J. Schneider | A. Mckee | J. Gilbert | Ruchita A Rajbhandary | B. Miller | J. Morris | J. Hardy | J. Haines | J. Morris | J. Morris | M. I. Kamboh | J. Schneider | F. Y. Demirci | D. Bennett

[1]  Thomas W. Mühleisen,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.

[2]  Nick C Fox,et al.  Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.

[3]  Nick C Fox,et al.  Common variants at ABCA 7 , MS 4 A 6 A / MS 4 A 4 E , EPHA 1 , CD 33 and CD 2 AP are associated with Alzheimer ’ s disease , 2011 .

[4]  K. Lunetta,et al.  Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. , 2010, Archives of neurology.

[5]  J. Gilbert,et al.  Dementia Revealed: Novel Chromosome 6 Locus for Late-Onset Alzheimer Disease Provides Genetic Evidence for Folate-Pathway Abnormalities , 2010, PLoS genetics.

[6]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[7]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[8]  Y. Pawitan,et al.  The pursuit of genome-wide association studies: where are we now? , 2010, Journal of Human Genetics.

[9]  Ming-Huei Chen,et al.  GWAF: an R package for genome-wide association analyses with family data , 2010, Bioinform..

[10]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[11]  P. Bosco,et al.  Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.

[12]  V. Pankratz,et al.  Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease , 2009, Nature Genetics.

[13]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[14]  J. Florez.  Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008. , 2008, The Journal of clinical endocrinology and metabolism.

[15]  Christoph Lange,et al.  Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.

[16]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.

[17]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[18]  Winnie S. Liang,et al.  GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.

[19]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[20]  Winnie S. Liang,et al.  GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. , 2007, Neuron.

[21]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[22]  G. Abecasis,et al.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.

[23]  G. Abecasis,et al.  Handling marker-marker linkage disequilibrium: pedigree analysis with clustered markers. , 2005, American journal of human genetics.

[24]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[25]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[26]  John P A Ioannidis,et al.  Commentary: meta-analysis of individual participants' data in genetic epidemiology. , 2002, American journal of epidemiology.

[27]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[28]  Lon R. Cardon,et al.  GRR: graphical representation of relationship errors , 2001, Bioinform..

[29]  P. Donnelly,et al.  Association mapping in structured populations. , 2000, American journal of human genetics.

[30]  P. Donnelly,et al.  Inference of population structure using multilocus genotype data. , 2000, Genetics.

[31]  M. Uhlén,et al.  Single-nucleotide polymorphism analysis by pyrosequencing. , 2000, Analytical biochemistry.

[32]  L Sun,et al.  Statistical tests for detection of misspecified relationships by use of genome-screen data. , 2000, American journal of human genetics.

[33]  E Lai,et al.  A 4-Mb high-density single nucleotide polymorphism-based map around human APOE. , 1998, Genomics.

[34]  C. Weinberg,et al.  Use and misuse of population attributable fractions. , 1998, American journal of public health.

[35]  K Johansson,et al.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[36]  U J Balis,et al.  The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. , 1997, BioTechniques.

[37]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[38]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[39]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[40]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[41]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[42]  Nature Genetics , 1991, Nature.

[43]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[44]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[45]  H. Rubash.  MASSACHUSETTS General Hospital. , 1957, Medical times.